Phibro Animal Health (PAHC) Operating Leases (2019 - 2026)

Phibro Animal Health's Operating Leases history runs 8 years deep, the most recent figure standing at $42.5 million for Q1 2026.

• On a quarterly basis, Operating Leases rose 26.42% year-over-year to $42.5 million in Q1 2026; TTM through Mar 2026 was $42.5 million, a 26.42% increase from a year earlier, with the FY2025 full-year figure at $33.7 million, up 12.79% from the prior year.
• Operating Leases advanced to $42.5 million in Q1 2026 per PAHC's latest filing, from $33.0 million in the prior quarter.
• Across five years, Operating Leases topped out at $42.5 million in Q1 2026 and bottomed at $28.3 million in Q4 2024.
• The 5-year median for Operating Leases is $30.3 million (2022), against an average of $31.7 million.
• Across the five-year window, Operating Leases decreased 10.62% in 2023 and advanced 26.42% in 2026, its largest moves.
• Year by year, Operating Leases stood at $29.8 million in 2022, then climbed by 4.79% to $31.2 million in 2023, then dropped by 9.23% to $28.3 million in 2024, then gained by 16.43% to $33.0 million in 2025, then rose by 28.94% to $42.5 million in 2026.
• Per Business Quant, the three latest PAHC Operating Leases figures stand at $42.5 million (Q1 2026), $33.0 million (Q4 2025), and $33.1 million (Q3 2025).